Singapore markets close in 6 hours 17 minutes
Straits Times Index
3,293.07 +5.32 (+0.16%) Nikkei
37,803.58 +175.10 (+0.47%) Hang Seng
17,549.41 +264.87 (+1.53%) FTSE 100
8,078.86 +38.48 (+0.48%) Bitcoin USD
64,437.01 +212.86 (+0.33%) CMC Crypto 200
1,392.48 +9.91 (+0.72%)
Pharmicell Co., Ltd. (005690.KS)
KSE - KSE Delayed price. Currency in KRW
Add to watchlist
As of 11:21AM KST. Market open.
Currency in KRW
Valuation measures4
| Market cap (intra-day) | 347.42B |
| Enterprise value | 336.43B |
| Trailing P/E | 96.50 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 6.14 |
| Price/book (mrq) | 4.32 |
| Enterprise value/revenue | 5.98 |
| Enterprise value/EBITDA | 39.86 |
Trading information
Stock price history
| Beta (5Y monthly) | -1.07 |
| 52-week change 3 | -36.16% |
| S&P500 52-week change 3 | 21.08% |
| 52-week high 3 | 9,660.00 |
| 52-week low 3 | 5,290.00 |
| 50-day moving average 3 | 5,874.80 |
| 200-day moving average 3 | 6,346.40 |
Share statistics
| Avg vol (3-month) 3 | 706.38k |
| Avg vol (10-day) 3 | 172.77k |
| Shares outstanding 5 | 60M |
| Implied shares outstanding 6 | 61.84M |
| Float 8 | 40.73M |
| % held by insiders 1 | 9.71% |
| % held by institutions 1 | 9.03% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 10:1 |
| Last split date 3 | 19 Dec 2011 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2013 |
| Most-recent quarter (mrq) | 30 Jun 2014 |
Profitability
| Profit margin | -111.85% |
| Operating margin (ttm) | -85.95% |
Management effectiveness
| Return on assets (ttm) | -4.98% |
| Return on equity (ttm) | -29.25% |
Income statement
| Revenue (ttm) | 23.94B |
| Revenue per share (ttm) | 548.73 |
| Quarterly revenue growth (yoy) | -58.20% |
| Gross profit (ttm) | N/A |
| EBITDA | -6.18B |
| Net income avi to common (ttm) | -26.78B |
| Diluted EPS (ttm) | N/A |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 9.44B |
| Total cash per share (mrq) | 209.31 |
| Total debt (mrq) | 11.74B |
| Total debt/equity (mrq) | 13.94% |
| Current ratio (mrq) | 1.34 |
| Book value per share (mrq) | N/A |
Cash flow statement
| Operating cash flow (ttm) | -7.55B |
| Levered free cash flow (ttm) | -5.79B |
© 2024 Yahoo. All rights reserved.